Comparison

BCR/ABL 210 kD fusion protein 259-269 (HLA-A*03:01) (HLA-A*11:01) European Partner

€58.00
Excl. VAT
Item no. EP11088_1
Manufacturer peptides & elephants
Amount 1 mg
Category
Type Peptides
Applications FC
Specific against Human (Homo sapiens)
ECLASS 10.1 32160409
ECLASS 11.0 32160409
UNSPSC 12352202
Alias ATGFKQSSK Human Bcr-abl 210 kD fusion protein HLA-A*03:01 HLA-A*11:01 Cancer Flow Cytometry
Available
Description
This peptide has high avidity for CD8 T cells, and can be used in the analysis of individual antigen-specific T cells. This product is a MHC pentamer of peptide composed BCR-ABL 210 kD fusion protein-derived peptide of ATGFKQSSK sequence covering 259-269 and A*03:01, A*11:01 molecule.
Keywords
ATGFKQSSK Human Bcr-abl 210 kD fusion protein HLA-A*03:01 HLA-A*11:01 Cancer Flow Cytometry
Sequence
ATGFKQSSK
N-Terminus
H
C-Terminus
OH
Purity
0, 95
Counter-Ion
TFA
Protein
Human Bcr-abl 210 kD fusion protein
Gene
BCR
Allele
HLA-A*03:01 HLA-A*11:01
Application
Flow Cytometry
Indication
Cancer
Storage
Store dry at -20°C

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 1 mg
Available: In stock
Listprice: €58.00
Price: €58.00
available

Delivery expected until 9/18/2025 

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close